HOSPITAL UNIVERSITARIO RUBER
Saila
Tokyo Medical University Hospital
Tokio, JapónTokyo Medical University Hospital-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
-
Pembrolizumab plus chemotherapy in Japanese patients with triple-negative breast cancer: Results from KEYNOTE-355
Cancer Medicine, Vol. 12, Núm. 9, pp. 10280-10293